Ripretinib

Qinlock

CompressaItalyAuthorised

In other countries

The same active substances on other registers, the same brand first.

QinlockCanada · 50 MG · Tablet · Deciphera Pharmaceuticals. LLCSame brand
Qinlock 50 MG ComprimidosSpain · 50 mg · comprimido · Deciphera Pharmaceuticals (Netherlands) B.V.Same brand
QinlockEuropean Union · Deciphera Pharmaceuticals (Netherlands) B.V.Same brand
QinlockCroatiaSame brand
Qinlock 50 mg tablettenNetherlands · Tablet · Deciphera Pharmaceuticals (Netherlands) B.V.Same brand
Qinlock Tablet 50 MGSingapore · 50.0 mg · tablet · Specialised Therapeutics Asia Pte LTDSame brand
QinlockUnited States · 50MG · tablet · Deciphera PharmsSame brand

Packs

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ripretinib

Qinlock

CompressaItalyAuthorised

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Pack	Code	Status
50 mg - Compressa - Uso orale - Flacone (HDPE) - 30 compresse	049792017	Autorizzata
50 mg - Compressa - Uso orale - Flacone (HDPE) - 90 compresse	049792029	Autorizzata

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Ripretinib
Dosage form: Compressa
Register: Italy (AIFA)
Status: Authorised
Status in the register: Autorizzata
Registration: AIC 049792
Marketing authorisation holder: Deciphera Pharmaceuticals (Netherlands) B.V.
ATC code: L01EX19
Group: Antineoplastic and immunomodulating agents
Procedure: Procedura Centralizzata
Supply: Medicinali soggetti a prescrizione medica limitativa, da rinnovare volta per volta, vendibili al pubblico su prescrizione di centri ospedalieri o di specialisti